District Court Interprets EKRA
FDA Law
JANUARY 6, 2022
In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs’ pay structure was important to the Court’s decision regarding the EKRA issue.
Let's personalize your content